Analysis | The Health 202: Drug maker accuses FDA of hampering its medication for opioid treatment

Deutschland Nachrichten Nachrichten

Analysis | The Health 202: Drug maker accuses FDA of hampering its medication for opioid treatment
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 washingtonpost
  • ⏱ Reading Time:
  • 54 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 25%
  • Publisher: 72%

The Health 202: Drug maker accuses FDA of hampering its medication for opioid treatment

Let’s zoom out for a moment. There’s broad consensus that combining counseling services with medication-assisted treatment is the best way to help people who are addicted to prescription painkillers, heroin or the synthetic opioid fentanyl.

When I asked Indivior for comment, the company sent a statement praising the medication and linking to studies showing its effectiveness, without addressing the orphan drug designation. “It’s very unusual or precedented – in my recollection – that a population for what is perceived to be a rare disease would grow to a point where it ends up being 10 times the cap for orphan drug designation,” said Bernard Munos, a former corporate strategy advisor at Eli Lilly.Derkacz contends it would result in fewer anti-opioid medications being available even as the public health agencies try to combat the epidemic.

Part of what led to the firing of Homeland Security Secretary Kirstjen Nielsen was reportedly tension between her and the president over Trump’s support for reinstating the administration’s family separation policy.Trump for months has been pushing his administration to revive the separation of families at the U.S. border with Mexico. They add an administration official said Trump believes the policy was effective in curbing asylum-seekers.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

washingtonpost /  🏆 95. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Analysis | The Health 202: A major insurer is announcing insulin savings amid heavy Hill pressureAnalysis | The Health 202: A major insurer is announcing insulin savings amid heavy Hill pressureThe Health 202: A major insurer is announcing insulin savings amid heavy Hill pressure
Weiterlesen »

Analysis | The Health 202: Pharmacy middlemen are under scrutiny for pushing up drug pricesAnalysis | The Health 202: Pharmacy middlemen are under scrutiny for pushing up drug pricesAnalysis: Pharmacy middlemen are under scrutiny for pushing up drug prices
Weiterlesen »

Analysis | The Health 202: HHS says it can't place unaccompanied migrant children with sponsors as fast as they're coming inAnalysis | The Health 202: HHS says it can't place unaccompanied migrant children with sponsors as fast as they're coming inThe Health 202: HHS says it can't place unaccompanied migrant children with sponsors as fast as they're coming in
Weiterlesen »

Health care is number one issue to voters: Texas DemHealth care is number one issue to voters: Texas DemRep. Colin Allred, D-Texas, discusses why health care is the number one issue in his district, what he's hearing from voters on health care and the way forward on health care.
Weiterlesen »

Health-insurance startups have raked in $1.3 billion in the past year. We took a look at their financials, which show how hard it is to get a foothold in the industry.Health-insurance startups have raked in $1.3 billion in the past year. We took a look at their financials, which show how hard it is to get a foothold in the industry.Here's a look at how companies such as Oscar Health, Bright Health, and Clover Health fared in 2018 — and what's ahead in 2019.
Weiterlesen »

For people with diabetes struggling to buy lifesaving insulin, a major health company is now offering the drug for just $25 a monthFor people with diabetes struggling to buy lifesaving insulin, a major health company is now offering the drug for just $25 a monthInsulin is a lifesaving product for individuals with diabetes. But it's also become incredibly expensive, sometimes prohibitively so for patients.
Weiterlesen »

Poll: Majority of voters don't trust Trump on health carePoll: Majority of voters don't trust Trump on health careThe poll shows that any health care battle will be fought on Democrats’ turf.
Weiterlesen »

U.S. health officials alarmed by polio-like illness affecting kidsU.S. health officials alarmed by polio-like illness affecting kidsAcute flaccid myelitis, or AFM, a rare paralyzing illness, is beginning to alarm public health officials because it is striking more kids.
Weiterlesen »



Render Time: 2025-03-10 20:31:29